1. Andrew Merron Executive Director, Oncology & Biosimilars
About Our Analyst
BIOGRAPHY Andrew Merron, Ph.D, is based in London and leads the global oncology team of 30 analysts and directors and is responsible for creating and directing broad oncology strategy, thought leadership, developing long-term strategic partnerships with clients, and translating domain knowledge into actionable solutions. Andrew has more than a decade of experience in commercial oncology analysis; his specific areas of expertise and interests include prostate cancer, hematological malignancies, real world evidence, clinical trial design, and clinical development strategies. He has extensive experience in forecasting oncology and hematology-oncology drug markets as well as considerable experience in conducting primary research with physicians and payers across the major pharmaceutical markets. Previously, Andrew led and managed the Biosimilars Advisory Service at Decision Resources; the Biosimilars Advisory Service spans multiple therapy areas including oncology.
Andrew Merron Executive Director, Oncology & Biosimilars
Follow Andrew Merron
| © 2018 DR/Decision Resources, LLC. All rights reserved.